<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2387883-B1" country="EP" doc-number="2387883" kind="B1" date="20140101" family-id="31720639" file-reference-id="317503" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146552777" ucid="EP-2387883-B1"><document-id><country>EP</country><doc-number>2387883</doc-number><kind>B1</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-11006213-A" is-representative="NO"><document-id mxw-id="PAPP154826700" load-source="docdb" format="epo"><country>EP</country><doc-number>11006213</doc-number><kind>A</kind><date>20030812</date><lang>EN</lang></document-id><document-id mxw-id="PAPP168024781" load-source="docdb" format="original"><country>EP</country><doc-number>11006213.0</doc-number><date>20030812</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140448649" ucid="EP-03749021-A" linkage-type="3" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>03749021</doc-number><kind>A</kind><date>20030812</date></document-id></priority-claim><priority-claim mxw-id="PPC140453619" ucid="US-40300402-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>40300402</doc-number><kind>P</kind><date>20020812</date></document-id></priority-claim><priority-claim mxw-id="PPC140451952" ucid="US-40316902-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>40316902</doc-number><kind>P</kind><date>20020812</date></document-id></priority-claim></priority-claims><dates-of-public-availability><intention-to-grant-date><date>20131024</date></intention-to-grant-date></dates-of-public-availability><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988096844" load-source="docdb">A61K   8/365       20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988097895" load-source="docdb">C11D   3/382       20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988098093" load-source="docdb">A61Q  19/10        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988098929" load-source="docdb">A61K   8/36        20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988099769" load-source="docdb">A61K  36/54        20060101A I20061202RMUS        </classification-ipcr><classification-ipcr mxw-id="PCL1988099998" load-source="docdb">A61K   8/41        20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988104904" load-source="docdb">A61K   8/368       20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988105322" load-source="docdb">A61K   8/97        20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988108158" load-source="docdb">A61K   8/33        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988109956" load-source="docdb">A01N  37/10        20060101AFI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988111881" load-source="docdb">A01N  25/02        20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988112616" load-source="docdb">A01N  43/50        20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988113756" load-source="docdb">A61Q  19/00        20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988115227" load-source="docdb">C11D   3/20        20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988116363" load-source="docdb">C11D   3/22        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988117303" load-source="docdb">A01N  37/06        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988117995" load-source="docdb">A01P   1/00        20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988118594" load-source="docdb">A61K   8/35        20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988121388" load-source="docdb">A61K   8/49        20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988123074" load-source="docdb">C11D   3/48        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988126408" load-source="docdb">A01N  43/08        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988126681" load-source="docdb">C11D   3/38        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988127256" load-source="docdb">A61L   2/18        20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988128915" load-source="docdb">A01N  43/16        20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988132512" load-source="docdb">A61Q   5/02        20060101ALI20120926BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988134427" load-source="docdb">A61K   8/34        20060101ALI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL1988135001" load-source="docdb">A01N  35/02        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988135447" load-source="docdb">A61K   8/00        20060101AFI20060310RMJP        </classification-ipcr><classification-ipcr mxw-id="PCL2065209416" load-source="docdb">A01N  65/00        20090101A I20140301RMEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2073227013" load-source="docdb" scheme="CPC">A01N  65/00        20130101 LI20150414BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073227731" load-source="docdb" scheme="CPC">A61Q  17/005       20130101 FI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073228619" load-source="docdb" scheme="CPC">A61K   8/33        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073229350" load-source="docdb" scheme="CPC">C11D   3/222       20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073229573" load-source="docdb" scheme="CPC">A61K   8/922       20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073231740" load-source="docdb" scheme="CPC">C11D   3/38        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073233102" load-source="docdb" scheme="CPC">A61Q  19/10        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073233809" load-source="docdb" scheme="CPC">A61Q   5/02        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073234146" load-source="docdb" scheme="CPC">A61K2800/524       20130101 LA20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073235014" load-source="docdb" scheme="CPC">C11D   3/2086      20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073235174" load-source="docdb" scheme="CPC">A01N  35/02        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073235554" load-source="docdb" scheme="CPC">A01N  37/06        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073235717" load-source="docdb" scheme="CPC">A01N  43/08        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073236474" load-source="docdb" scheme="CPC">A61L   2/18        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073236554" load-source="docdb" scheme="CPC">C11D   3/382       20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073237834" load-source="docdb" scheme="CPC">C11D   3/48        20130101 LI20150416BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073238367" load-source="docdb" scheme="CPC">C11D   3/2075      20130101 LI20150416BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132190815" lang="DE" load-source="patent-office">Benzoesäure enthaltende antimikrobielle Zusammensetzungen</invention-title><invention-title mxw-id="PT132190816" lang="EN" load-source="patent-office">Antimicrobial compositions comprising benzoic acid</invention-title><invention-title mxw-id="PT132190817" lang="FR" load-source="patent-office">Compositions antimicrobiennes contenant de l'acide benzoïque</invention-title><citations><non-patent-citations><nplcit><text>2 September 2009, LONZA LIFE SCIENCE INGREDIENTS - MICROBIAL CONTROL EUROPE, article "Geogard (Tm) Ultra - Product Information", pages: 1 - 5, XP055078147</text><sources><source mxw-id="PNPL64149640" load-source="docdb" name="EXA"/></sources></nplcit></non-patent-citations></citations></technical-data><related-documents><relation type="division"><child-doc ucid="EP-11006213-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>11006213</doc-number><kind>A</kind><date>20030812</date></document-id></child-doc><parent-doc ucid="EP-03749021.6"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>03749021.6</doc-number><date>20030812</date></document-id></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR918173250" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>LONZA AG</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR918139734" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>LONZA INC.</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918167271" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>LUTZ PATRICK JAY</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918156242" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>LUTZ, PATRICK JAY</last-name></addressbook></inventor><inventor mxw-id="PPAR918995521" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>LUTZ, PATRICK JAY</last-name><address><street>5735 Kesslerville Road</street><city>Nazareth, PA 18064</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918158649" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>BOROKHOV OLGA</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918170119" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>BOROKHOV, OLGA</last-name></addressbook></inventor><inventor mxw-id="PPAR918995522" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>BOROKHOV, OLGA</last-name><address><street>c/o Sybron Dental Specialities 1717 West Collins Avenue</street><city>Orange, CA 92867</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918155899" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>SHIBU ABRAHAM</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918169428" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>Shibu, Abraham</last-name></addressbook></inventor><inventor mxw-id="PPAR918995525" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>Shibu, Abraham</last-name><address><street>9 Spring Run Lane</street><city>Stewartsville, NJ 08886</city><country>US</country></address></addressbook></inventor></inventors><assignees><assignee mxw-id="PPAR918995524" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>LONZA INC.</last-name><iid>100753959</iid><address><street>90 Boroline Road</street><city>Allendale, NJ 07401-1613</city><country>US</country></address></addressbook></assignee></assignees><agents><agent mxw-id="PPAR918995523" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Riegler, Norbert Hermann</last-name><suffix>et al</suffix><iid>101222633</iid><address><street>Lonza Ltd. Patent Department Münchensteinerstrasse 38</street><city>4052 Basel</city><country>CH</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS548957720" load-source="docdb">AT</country><country mxw-id="DS548879231" load-source="docdb">BE</country><country mxw-id="DS548850848" load-source="docdb">BG</country><country mxw-id="DS548957587" load-source="docdb">CH</country><country mxw-id="DS548879232" load-source="docdb">CY</country><country mxw-id="DS548966680" load-source="docdb">CZ</country><country mxw-id="DS548969347" load-source="docdb">DE</country><country mxw-id="DS548879233" load-source="docdb">DK</country><country mxw-id="DS548879234" load-source="docdb">EE</country><country mxw-id="DS548961254" load-source="docdb">ES</country><country mxw-id="DS548850849" load-source="docdb">FI</country><country mxw-id="DS548850850" load-source="docdb">FR</country><country mxw-id="DS548969348" load-source="docdb">GB</country><country mxw-id="DS548879235" load-source="docdb">GR</country><country mxw-id="DS548966681" load-source="docdb">HU</country><country mxw-id="DS548957588" load-source="docdb">IE</country><country mxw-id="DS548850851" load-source="docdb">IT</country><country mxw-id="DS548879288" load-source="docdb">LI</country><country mxw-id="DS548957721" load-source="docdb">LU</country><country mxw-id="DS548850852" load-source="docdb">MC</country><country mxw-id="DS548957726" load-source="docdb">NL</country><country mxw-id="DS548961255" load-source="docdb">PT</country><country mxw-id="DS548825095" load-source="docdb">RO</country><country mxw-id="DS548957727" load-source="docdb">SE</country><country mxw-id="DS548969349" load-source="docdb">SI</country><country mxw-id="DS548957589" load-source="docdb">SK</country><country mxw-id="DS548879289" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><description mxw-id="PDES63956935" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001"><b><u>Field of the Invention</u></b></heading><p id="p0001" num="0001">The present invention relates to personal care products comprising antimicrobial compositions, and methods of killing and/or inhibiting the growth or microorganisms.</p><heading id="h0002"><b><u>Background of the Invention</u></b></heading><p id="p0002" num="0002">Natural products, while often safe, are generally expensive and do not have biocidal efficacy against a broad spectrum of organisms such as gram negative and positive bacteria and fungi. Most natural products are only effective against gram positive bacteria at relatively high concentrations and are not effective against gram negative bacteria or fungi.<!-- EPO <DP n="2"> --></p><p id="p0003" num="0003">There is a continuing need for low cost and safe preservative systems which are effective against a broad spectrum of microorganisms.<br/>
<patcit id="pcit0001" dnum="US5683737A"><text>US 5 683 737 A</text></patcit> discloses mayonnaise and dressing compositions having a δ-gluconolactone-based preservative system. <patcit id="pcit0002" dnum="US4011346A"><text>US 4 011 346</text></patcit> discloses pet foods comprising acidic bacteriostatic agents, such as δ-gluconolactone, combined with edible antimycotics such as benzoic acid.<br/>
<patcit id="pcit0003" dnum="US5336500A"><text>US 5 336 500</text></patcit> discloses synergistic disinfectant compositions comprising sorbic and benzoic acid and an aqueous mono- and polyhydric alcohol solvent system. The compositions are suitable i.a. for incorporation into hand wipes, creams or soap.</p><heading id="h0003"><b><u>Summary of the Invention</u></b></heading><p id="p0004" num="0004">The present invention provides a personal care product comprising an antimicrobial composition comprising an antimicrobial effective amount (such as a preservative, bactericidal, and/or fungicidal effective amount) of a mixture comprising
<ol><li>(a) benzoic acid, or a salt thereof; and</li><li>(b) δ-gluconolactone</li></ol>
and, optionally, one or more of:
<ul><li>(c) lemon-grass oil;</li><li>(d) cinnamaldehyde;</li><li>(e) sorbic acid, or a salt thereof;</li><li>(f) erythorbic acid, or a salt thereof;</li><li>(g) arabinogalactan, (galactoarabinan);</li><li>(h) a hexahydro-iso-alpha-acid, or tetrahydro-iso-alpha-acid obtainable from hops extracts, or a mixture thereof;</li><li>(i) Achillea fragrantissima (Santolina fragrantissima Forssk., Lavender cotton)oil.</li></ul>
The product may be solid or liquid.<br/>
Preferably the mixtures of the present invention include an antimicrobial (e.g., preservative, bactericidal, and/or fungicidal) synergistic effective amount of the aforementioned ingredients.</p><p id="p0005" num="0005">Antimicrobial compositions comprised in the personal care product of the present invention include, those shown below.<!-- EPO <DP n="3"> --><!-- EPO <DP n="4"> -->
<tables id="tabl0001" num="0001"><table frame="all"><tgroup cols="2" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78mm"/><colspec colnum="2" colname="col2" colwidth="35mm"/><thead><row><entry align="center" valign="top">Component (a)</entry><entry align="center" valign="top">Component (b)</entry></row></thead><tbody><row><entry rowsep="1">benzoic acid or a salt thereof (e.g., sodium benzoate)</entry><entry rowsep="1">glucono delta lactone</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="5"> --></p><p id="p0006" num="0006">In the aforementioned mixtures containing glucono delta lactone, the glucono delta lactone potentiates the antimicrobial efficacy of the preservative (benzoic acid) in the mixture.</p><p id="p0007" num="0007">Another embodiment is a method of killing and/or inhibiting the growth of microorganisms on a substrate being a personal care product by applying an effective amount of the antimicrobial composition of the present invention to the substrate or the product.</p><p id="p0008" num="0008">Yet another embodiment is a method of preserving a product (e.g., a personal care product) by incorporating a preservative effective amount of the antimicrobial composition of the present invention into the product.<!-- EPO <DP n="6"> --></p><p id="p0009" num="0009">The formulations and products of the present invention preferably have a pH less than 10, 9, 8.5, or 8.<!-- EPO <DP n="7"> --></p><heading id="h0004"><b><u>Detailed Description of the Invention</u></b></heading><heading id="h0005"><u>Definitions</u></heading><p id="p0010" num="0010">The term "microorganisms" includes, but is not limited to, bacteria, fungi, yeasts, algae, insects, and pests.</p><p id="p0011" num="0011">The term "about" or "approximately" means within an acceptable error range for the particular value as determined by one of ordinary skill in the art, which will depend in part on how the value is measured or determined, i.e., the limitations of the measurement system. For example, "about" can mean within 1 or more than 1 standard deviations, per the practice in the art. Alternatively, "about" can mean a range of up to 20%, preferably up to 10%, more preferably up to 5%, and more preferably still up to 1% of a given value. Alternatively, particularly with respect to biological systems or processes, the term can mean within an order of magnitude, preferably within 5-fold, and more preferably within 2-fold, of a value. Where particular values are described in the application and claims, unless otherwise stated the term "about" meaning within an acceptable error range for the particular value should be assumed.<!-- EPO <DP n="8"> --></p><p id="p0012" num="0012">The term "personal care products" refers to products intended for application to the human body, such as to skin, hair, and nails, including, but not limited to, shampoos, conditioners, creams, lotions (such as body lotions), cosmetics, and soaps.</p><p id="p0013" num="0013">The term "smelling effective amount" refers to a sufficent amount of an agent incorporated into a product to give the product an odor.</p><p id="p0014" num="0014">The term "potentiating" refers to the ability of a compound or composition to enhance or increase the effect of an antimicrobial compound or composition. Preferably, the efficacy of the combined mixture is greater than the additive effect of the ingredients.</p><p id="p0015" num="0015">Suitable salts of sorbic acid, erythorbic acid, and benzoic acid include, but are not limited to, alkali metal or alkali earth metal salts, such as potassium and sodium.</p><heading id="h0006"><u>Components for Mixtures</u></heading><p id="p0016" num="0016">Cinnamaldehyde from any source may be used in the present invention. For example, the cinnamaldehyde may be derived from cinnamon bark extracts (such as from bark and leaf), cassia leaf oil, cinnamomum cassia, cinnamon oils, cinnamal, and mixtures thereof.</p><p id="p0017" num="0017">A preferred salt of sorbic acid is potassium sorbate.</p><p id="p0018" num="0018">A preferred salt of erythorbic acid is sodium erythorbate.</p><p id="p0019" num="0019">A preferred salt of benzoic acid is sodium benzoate.</p><p id="p0020" num="0020">Arabinogalactan (galactoarabinan) may be derived from Larex trees. Arabinogalactan is available as Larex UF<sup>™</sup> from Larex Inc. of White Bear Lake, MN.</p><p id="p0021" num="0021">Hexahydro -iso-alpha-acids and tetrahydro-iso-alpha-acids are those obtained from hops extracts, such as Hexahop Gold<sup>™</sup> (also referred to as Hexahop herein) available from John I. Haas, Inc. of Washington, D.C.<!-- EPO <DP n="9"> --></p><p id="p0022" num="0022">According to a specific embodiment, the antimicroial composition contains at least 0.1% of sorbic acid, or a salt thereof, such as potassium sorbate.</p><heading id="h0007"><u>Examples of Preferred Mixtures</u></heading><!-- EPO <DP n="10"> --><p id="p0023" num="0023">It has been surprisingly found that glucono delta lactone potentiate the biocidal efficacy of benzoic acid and salts thereof.</p><p id="p0024" num="0024">Preferred mixtures include, but are not limited to, those below. Preferred and more preferred weight ratios are also provided.<!-- EPO <DP n="11"> -->
<tables id="tabl0002" num="0002"><table frame="all"><tgroup cols="4" rowsep="0"><colspec colnum="1" colname="col1" colwidth="37mm"/><colspec colnum="2" colname="col2" colwidth="46mm"/><colspec colnum="3" colname="col3" colwidth="39mm"/><colspec colnum="4" colname="col4" colwidth="44mm"/><thead><row><entry align="center" valign="top">Component (a)</entry><entry align="center" valign="top">Component (b)</entry><entry align="center" valign="top">Preferred Weight Ratio</entry><entry align="center" valign="top">More Preferred Weight Ratio</entry></row></thead><tbody><row><entry rowsep="1">Glucono Delta Lactone</entry><entry rowsep="1">Benzoic Acid or a Salt Thereof</entry><entry rowsep="1">about 0.1:1 to about 20:1</entry><entry rowsep="1">about 0.2:1 to about 5:1</entry></row></tbody></tgroup></table></tables></p><p id="p0025" num="0025">More preferred mixtures include, but are not limited to, those shown below.<!-- EPO <DP n="12"> -->
<tables id="tabl0003" num="0003"><table frame="all"><tgroup cols="4" rowsep="0"><colspec colnum="1" colname="col1" colwidth="37mm"/><colspec colnum="2" colname="col2" colwidth="30mm"/><colspec colnum="3" colname="col3" colwidth="37mm"/><colspec colnum="4" colname="col4" colwidth="44mm"/><thead><row><entry align="center" valign="top">Component (a)</entry><entry align="center" valign="top">Component (b)</entry><entry align="center" valign="top">Preferred Weight Ratio</entry><entry align="center" valign="top">More Preferred Weight Ratio</entry></row></thead><tbody><row><entry rowsep="1">Glucono Delta Lactone</entry><entry rowsep="1">Sodium Benzoate</entry><entry rowsep="1">about 1:1 to about 5:1</entry><entry rowsep="1">about 3:1</entry></row></tbody></tgroup></table></tables></p><heading id="h0008"><u>Antimicrobial Compositions</u></heading><p id="p0026" num="0026">The antimicrobial compositions are useful as antimicrobial, fungicidal, and bactericidal agents and as preservatives in personal care products. The antimicrobial composition is incorporated into or be a personal care product, such as a shampoo, conditioner, cream, lotion (such as body lotion), cosmetic, or soap.<!-- EPO <DP n="13"> --></p><p id="p0027" num="0027">The product contains an antimicrobial, preservative, bactericidal, and/or fungicidal effective amount of the antimicrobial composition. According to one embodiment, the product contains from about 0.01 to about 2.0% by weight of each component of the antimicrobial composition, based upon 100% total weight of product. According to another embodiment, the product includes from about 0.1 to about 1 or 2% by weight of the antimicrobial composition, based upon 100% weight of total product.<!-- EPO <DP n="14"> --></p><p id="p0028" num="0028">Generally, the antimicrobial composition and preservative system of the present invention acts quickly (e.g., reduces the microorganism (e.g., bacteria and/or fungi) count by 95, 99, 99.9, or 99.99% typically within an hour) and maintains efficacy (e.g., maintains less than 10 cfu/g) over long periods of time (e.g., for at least 7, 10, 14, or 28 days). The term "preservative effective amount" refers to an amount of the preservative system which maintains the microorganism count below 1000, 100, or 10 cfu/g for at least 1, 4, 7, 10, 14, or 28 days.</p><p id="p0029" num="0029">The antimicrobial composition and preservative system may include a solvent, such as water and water miscible solvents, including, but not limited to, alcohols (e.g., methanol, ethanol, propanol, iso-propanol, and butanol), glycols (e.g. glycerin, diglycerin, butylene glycol, butoxydiglycol, propylene glycol, and dipropylene glycol), esters, ethers, polyethers, and any combination of any of the foregoing. For example, the solvent may comprise water and one or more glycol and/or one or more alcohol, such as glycerin, phenoxyethanol, benzyl alcohol, or ethanol. A specific solvent system comprises water and and a glycol, such as glycerin. A second specific solvent system comprises water and an alcohol, such as ethanol.</p><p id="p0030" num="0030">Other adjuvants may be included in the antimicrobial composition and preservative system as known to one of ordinary skill in the art. Suitable adjuvants include, but are not limited to, preservatives; solubilizing agents; chelating agents, such as ethylenediaminetetraacetic acid (EDTA) and salts thereof and zeolites; surfactants, such as cationic, anionic, nonionic, and amphoteric surfactants; antioxidants, such as butylated hydroxyanisole (BHA) and butylhydroxytoluene (BHT); amine oxides; tertiary amines; zinc compounds; hydrotropes; fluoride compounds; magnesium salts; calcium salts; carboxylic acids; phosphates; phosphonates; formaldehyde donors; glycereth-7; myristyl myristate; glutaraldehydes; biguanides; natural products, such as geranoil, usnic acid, and tea tree oils;<!-- EPO <DP n="15"> --> and any combination of any of the foregoing. Suitable preservatives include, but are not limited to, quaternary ammonium chlorides; quaternary ammonium carbonates; benzalkonium chloride; iodine containing compounds, such as 3-iodo-2-propynyl butyl carbamate (IPBC); hydantoins, such as dimethylhydantoin and halogenated hydantoins; isothiazolinones; parabens, such as methylparaben, ethylparaben, and propylparaben; dehydroacetic acid and salts thereof; isocil; chloroxylenol; chlorhexidine; phenoxyethanol; benzyl alcohol; phenethyl alcohol; benzoic acid and salts thereof such as sodium benzoate; chlorobutanol; sorbic acid and salts thereof; triclosan; triclocarban; and any combination of any of the foregoing.</p><p id="p0031" num="0031">The antimicrobial composition and preservative system may be incorporated into an aqueous or oil based system or an emulsion. A suitable solvent for an oil based system is phenoxyethanol and/or benzyl alcohol.</p><p id="p0032" num="0032">The antimicrobial composition can be a liquid or a solid.</p><p id="p0033" num="0033">When the synergistic mixture contains only two ingredients from the list above, the weight ratio of the first component to the second component typically ranges from about 0.01:100 to about 100:0.01, preferably ranges from about 0.1:20 to about 20:0.1, and more preferably ranges from about 1:10 to about 10:1. When the synergistic mixture contains three components, the third component can be in any amount, but typically the weight ratio of the third component to either of the first two components is from about 0.01:100 to about 100:0.01.</p><p id="p0034" num="0034">To prepare a formulation containing the product of the present invention, a concentrate of the antimicrobial composition and preservative system is generally first prepared. The concentrate may include from about 0.01 to about 100% by weight of the antimicrobial composition and preservative system and preferably contains from about 5 to about 80% by weight of the antimicrobial composition, based upon 100% total weight of concentrate. For a two-component antimicrobial composition, the concentrate broadly<!-- EPO <DP n="16"> --> contains from about 0.01 to about 99.99% by weight of the first component and from about 99.99% to about 0.01% by weight of the second component (based upon 100% total weight of concentrate).</p><p id="p0035" num="0035">Before use, the concentrate is diluted, preferably with the same solvent as was used in the concentrate, and/or incorporated into a product. Use dilutions of the composition typically comprise an antimicrobial, preservative, fungicidally, or bactericidally effective amount of the antimicrobial composition or preservative system.</p><p id="p0036" num="0036">Generally, use dilutions contain from about 0.0001% or 0.01 % to about 2% by weight of the concentrate. According to one preferred embodiment, use dilutions contain from about 0.1 to about 1% by weight of the concentrate. In more preferred embodiments, the use dilution contains 0.2, 0.25 or 0.30% by weight of the concentrate. The use dilution generally contains from about 0.01, to about 2.0% by weight of each<!-- EPO <DP n="17"> --> antimicrobial ingredient, based upon 100% total weight of use dilution. According to a preferred embodiment, the antimicrobial composition contains from about 0.001 to about 10%, preferably from about 0.01 to about 1%, and more preferably from about 0.05 to about 0.5% by weight of each antimicrobial ingredient.</p><p id="p0037" num="0037">According to another embodiment, the aforementioned preservative system is incorporated into a product at a concentration of about 0.1 to about 1 or 2% by weight, based upon 100% total weight of product.</p><p id="p0038" num="0038">Another embodiment of the present invention is a method for inhibiting the growth of microorganisms, bacteria (e.g., S. <i>aureus</i> (ATCC # 6538), <i>P. aeruginosa</i><!-- EPO <DP n="18"> --> (ATCC # 9027), and E. <i>coli</i> (ATCC # 8739)), and/or fungi (including plant and tree fungi) (e.g., <i>Candida albicans, Aspergillus niger and Phytophthora ramrum</i>) on a substrate by applying an antimicrobial, preservative, bactericidal, or fungicidal effective amount of the antimicrobial composition or preservative system of the present invention to the substrate. The antimicrobial composition or preservative system may be applied to the substrate by any method known in the art including, but not limited to, brushing, dipping, soaking, vacuum impregnation, and pressure treatment.</p><p id="p0039" num="0039">The antimicrobial composition of the present invention may be prepared by mixing the antimicrobial components, and optionally, solvents, and adjuvants. The mixture may be heated and/or stirred to expedite mixing.</p><heading id="h0009"><b><u>Examples</u></b></heading><p id="p0040" num="0040">The following examples illustrate the invention without limitation. All parts and percentages are given by weight unless otherwise indicated.</p><heading id="h0010">Reference <u>Example 1</u></heading><p id="p0041" num="0041">Each anionic shampoo sample in Figures 1-3 were tested as follows. A standardized mixed bacterial solution was prepared according to the following procedure. 3 agar stabs of S. <i>aureus</i> (ATCC # 6538), <i>P. aeruginosa</i> (ATCC # 9027), and <i>E. coli</i> (ATCC # 8739) were separately incubated at about 35 °C for about 24 hours. Each stab was then washed with 3 mL of sterile 0.85% saline solution. The washes of the 3 stabs were pooled<!-- EPO <DP n="19"> --> together to form an organism mixture. The absorbance of the organism mixture at 530 nm was adjusted to about 1.00 by adding saline. The spectrometer was calibrated with a saline blank. A 5 mL aliquot of the organism mixture was mixed together to produce the standardized mixed bacterial solution. Then, 40 g of each shampoo sample was inoculated with 0.2 mL of the standardized mixed bacterial solution and mixed. 1 g of the mixture was added to a sterile 20 × 150 mm screw cap test tube.</p><p id="p0042" num="0042">9 mL of sterile D/E neutralizer broth was added to the test tube and mixed to form a 10<sup>-1</sup> dilution. Serial dilutions were prepared through to a 10<sup>-6</sup> dilution with phosphate buffered water. The serial dilutions were plated onto Tryptic Soy Agar and incubated for 2 days at about 35 °C. Bacteria counts were performed after 21 days.</p><p id="p0043" num="0043">The anionic protein shampoo composition was comprised of 35% by weight of sodium lauryl ether sulfate; 25% by weight of triethanolamine lauryl sulfate; 3% by weight coconut diethanolamide (cocamide DEA); 1% by weight of hydrolyzed collagen, available as Polypro 5000<sup>™</sup> from Hormel Foods of Austin, MN; and 36% by weight of deionized water.</p><p id="p0044" num="0044">The antimicrobial composition containing samples were prepared by mixing the appropriate amounts of the antimicrobial ingredients and the aforementioned anionic protein shampoo composition and heating the mixture to about 50 °C for about 15 minutes.</p><heading id="h0011">Reference <u>Example 2</u></heading><p id="p0045" num="0045">Each anionic shampoo sample were tested as follows. A standard mixed bacterial solution was prepared according to the following procedure. 2 agar slants of <i>Candida albicans</i> and 4 agar slants of <i>Aspergillus niger</i> were separately incubated at<!-- EPO <DP n="20"> --> about 25 °C for about 48 hours and 7 days, respectively. Each slant was washed with 3 mL of sterile 0.85% saline solution, collected and macerated in atissue grinder. Sufficient amounts of 0.85% saline solution were added to each slant to obtain a visual count under a microscope with a Neubauer Hemocytometer of each innoculum of <i>C</i>. <i>albicans</i> and <i>A. niger.</i> Equal volumes of each standardized innoculum of <i>C</i>. <i>albicans</i> and <i>A. niger</i> were mixed together to form the standardized mixed fungal solution.</p><p id="p0046" num="0046">40 g of each shampoo sample was inoculated with 0.4 mL of the standardized mixed fungal solution and mixed. 1 g of the mixture was added to a sterile 20 × 150mm screw cap test tube.</p><p id="p0047" num="0047">9 mL of sterile D/E neutralizer broth was added to the test tube and mixed to form a 10<sup>-1</sup> dilution. Serial dilutions were prepared through to a 10<sup>-6</sup> dilution with phosphate buffered water. The serial dilutions were plated onto Sabourand dextrose agar and incubated 5 days at about 25 °C. Fungal counts were performed after 0, 7, and/or 14 days.</p><p id="p0048" num="0048">The anionic protein shampoo composition is described in Example 1. The shampoo samples were prepared by mixing the appropriate amounts of the antimicrobial ingredients and the anionic protein shampoo composition and heating the mixture to about 50 °C for about 15 minutes.</p><heading id="h0012">Reference <u>Example 3</u></heading><p id="p0049" num="0049">The procedure described in Example 1 was repeated with the preservative formulations set forth in Table 1 below. The pH of the shampoo was adjusted to 6.5. The results are also shown in Table 1.<!-- EPO <DP n="21"> -->
<tables id="tabl0004" num="0004"><table frame="all"><title><u>Table 1</u></title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="76mm"/><colspec colnum="2" colname="col2" colwidth="22mm"/><colspec colnum="3" colname="col3" colwidth="22mm"/><colspec colnum="4" colname="col4" colwidth="24mm"/><colspec colnum="5" colname="col5" colwidth="24mm"/><thead><row><entry align="center">Preservative Formulation</entry><entry align="center" valign="middle">Day 0 cfu/g.</entry><entry align="center" valign="middle">Day 7 cfu/g.</entry><entry align="center" valign="middle">Day 14 cfu/g.</entry><entry align="center" valign="middle">Day 28 cfu/g.</entry></row></thead><tbody><row><entry valign="bottom">0.3% w/w of a mixture containing 75% potassium sorbate and 25% sodium erythorbate</entry><entry align="center" valign="middle">1-3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&lt;10</entry><entry align="center" valign="middle">&lt;10</entry><entry align="center" valign="middle">&lt;10</entry></row><row><entry valign="bottom">0.3% w/w of a mixture containing 75% sodium benzoate and 25% sodium erythorbate</entry><entry align="center" valign="middle">1-3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&lt;10</entry><entry align="center" valign="middle">&lt;10</entry><entry align="center" valign="middle">&lt;10</entry></row><row><entry valign="bottom">0.45% w/w sodium erythorbate</entry><entry align="center" valign="middle">1-3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&gt;3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&gt;3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&gt;3 × 10<sup>6</sup></entry></row><row><entry valign="bottom">0.45% w/w sodium benzoate</entry><entry align="center" valign="middle">1-3 × 10<sup>6</sup></entry><entry align="center" valign="middle">1 × 10<sup>5</sup></entry><entry align="center" valign="middle">7 × 10<sup>5</sup></entry><entry align="center" valign="middle">&lt;10</entry></row><row><entry valign="bottom">0.45% w/w potassium sorbate</entry><entry align="center" valign="middle">1-3 × 10<sup>6</sup></entry><entry align="center" valign="middle">1 × 10<sup>5</sup></entry><entry align="center" valign="middle">6 × 10<sup>4</sup></entry><entry align="center" valign="middle">N.D.</entry></row><row><entry valign="bottom">Unpreserved Shampoo</entry><entry align="center" valign="middle">1-3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&gt;3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&gt;3 × 10<sup>6</sup></entry><entry align="center" valign="middle">&gt;3 × 10<sup>6</sup></entry></row></tbody></tgroup></table></tables></p><p id="p0050" num="0050">From Table 1, synergism for (1) a 0.3% dilution of potassium sorbate (75%) and sodium erythorbate (25%) and (2) a 0.3% dilution of sodium benzoate (75%) and sodium erythorbate (25%) against mixed bacteria in shampoo was calculated by the method described in <nplcit id="ncit0001" npl-type="s"><text>C.E. Kull et al., "Mixtures of Quaternary Ammonium Compounds and Long-chain Fatty Acids as Antifungal Agents", Applied Microbiology, 9:538-541 (1961</text></nplcit>). The synergism value (Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub>) was determined. Q<sub>A</sub> is the concentration of potassium sorbate or sodium benzoate (in percent by weight) in the mixture, which yielded 100% retardation of the bacteria, <i>i.e.</i>, resulted in a plate count of &lt;10 cfu/g after 7 days. Q<sub>a</sub> is the concentration of potassium sorbate or sodium benzoate alone (in percent by weight) required to yield 100% retardation of the bacteria. Q<sub>B</sub> is the concentration of sodium erythorbate (in percent by weight) in the mixture, which yielded 100% retardation of the bacteria. Q<sub>b</sub> is the concentration of sodium erythorbate alone (in percent by weight) required to yield 100% retardation of the bacteria.<!-- EPO <DP n="22"> --></p><p id="p0051" num="0051">When the value of (Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub>) is less than one, the mixture is synergistic. Values for (Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub>) of 1 and greater represent an additive effect and an antagonistic effect, respectively. The results are shown in Table 2 below.
<tables id="tabl0005" num="0005"><table frame="all"><title><u>Table 2</u></title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="77mm"/><colspec colnum="2" colname="col2" colwidth="15mm"/><colspec colnum="3" colname="col3" colwidth="15mm"/><colspec colnum="4" colname="col4" colwidth="14mm"/><colspec colnum="5" colname="col5" colwidth="14mm"/><colspec colnum="6" colname="col6" colwidth="27mm"/><thead><row><entry align="center" valign="top">Preservative Mixture</entry><entry align="center" valign="top">Q<sub>A</sub></entry><entry align="center" valign="top">Q<sub>B</sub></entry><entry align="center" valign="top">Q<sub>a</sub></entry><entry align="center" valign="top">Q<sub>b</sub></entry><entry align="center" valign="top">Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub></entry></row></thead><tbody><row><entry align="center">75% potassium sorbate and 25% sodium erythorbate</entry><entry align="center">0.225%</entry><entry align="center">0.075%</entry><entry align="center">0.45%</entry><entry align="center">0.45%</entry><entry align="center">0.67 (&lt;1)</entry></row><row><entry align="center">75% Sodium Benzoate and 25% Sodium erythorbate</entry><entry align="center">0.225%</entry><entry align="center">0.075%</entry><entry align="center">0.45%</entry><entry align="center">0.45%</entry><entry align="center">0.67</entry></row></tbody></tgroup></table></tables></p><heading id="h0013">Reference <u>Example 4</u></heading><p id="p0052" num="0052">Each anionic shampoo sample in Table 3 below was tested as follows. A standardized mixed bacterial solution was prepared according to the following procedure. 3 agar stabs of <i>S. aureus</i> (ATCC # 6538), <i>P. aeruginosa</i> (ATCC # 9027), and <i>E. coli</i> (ATCC # 8739) were separately incubated at about 35 °C for about 24 hours. Each stab was then washed with 3 mL of sterile 0.85% saline solution. The washes of the 3 stabs were pooled together to form an organism mixture. The absorbance of the organism mixture at 530 nm was adjusted to about 1.00 by adding saline. The spectrometer was calibrated with a saline blank. A 5 mL aliquot of the organism mixture was mixed together to produce the standardized mixed bacterial solution. Then, 40 g of each shampoo sample was inoculated with 0.2 mL of the standardized mixed bacterial solution and mixed. 1 g of the mixture was added to a sterile 20 x 150 mm screw cap test tube.</p><p id="p0053" num="0053">9 mL of sterile D/E neutralizer broth was added to the test tube and mixed to form a 10<sup>-1</sup> dilution. Serial dilutions were prepared through to a 10<sup>-6</sup> dilution with phosphate buffered water. The serial dilutions were plated onto Tryptic Soy Agar and<!-- EPO <DP n="23"> --> incubated for 2 days at about 35 °C. Bacteria counts were performed after 0, 7, and 14 days. The results are shown in Table 1.</p><p id="p0054" num="0054">The anionic protein shampoo composition was comprised of 35% by weight of sodium lauryl ether sulfate; 25% by weight of triethanolamine lauryl sulfate; 3% by weight coconut diethanolamide (cocamide DEA); 1% by weight of hydrolyzed collagen, available as Polypro 5000<sup>™</sup> from Hormel Foods of Austin, MN; and 36% by weight of deionized water.</p><p id="p0055" num="0055">The cinnamaldehyde and other preservative containing samples were prepared by mixing the appropriate amounts of the preservatives and the aforementioned anionic protein shampoo composition and heating the mixture to about 50 °C for about 15 minutes.
<tables id="tabl0006" num="0006"><table frame="all"><title><u>Table 3</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="75mm"/><colspec colnum="2" colname="col2" colwidth="31mm"/><colspec colnum="3" colname="col3" colwidth="31mm"/><colspec colnum="4" colname="col4" colwidth="31mm"/><thead><row><entry morerows="1" align="center" valign="top">Shampoo</entry><entry namest="col2" nameend="col4" align="center" valign="top"><i>S. aureus</i>, <i>P. aeruginosa</i>, and <i>E. coli</i> (cfu/g)</entry></row><row><entry align="center" valign="top">Day 0</entry><entry align="center" valign="top">Day 7</entry><entry align="center" valign="top">Day 14</entry></row></thead><tbody><row><entry>Unpreserved Anionic Protein Shampoo Composition</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>0.25% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">&lt;10</entry><entry align="center">&lt;10</entry></row><row><entry>0.20% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">&lt;10</entry><entry align="center">&lt;10</entry></row><row><entry>0.10% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">1.0 × 10<sup>1</sup></entry><entry align="center">&lt;10</entry></row><row><entry>1.0% Benzyl Alcohol</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">5.0 × 10<sup>6</sup></entry><entry align="center">5.3 × 10<sup>6</sup></entry></row><row><entry>1.0% LiquaPar Optima*</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">2.0 × 10<sup>7</sup></entry></row><row><entry>1% Tea Tree Oil</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>1% d-Limonene</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>1% Gerniol</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><!-- EPO <DP n="24"> --><row><entry>1% Nerol</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>1% Citral</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>1% Eugenol</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>1% Hexahop</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row></tbody></tgroup><tgroup cols="4" rowsep="0"><colspec colnum="1" colname="col1" colwidth="75mm"/><colspec colnum="2" colname="col2" colwidth="31mm"/><colspec colnum="3" colname="col3" colwidth="31mm"/><colspec colnum="4" colname="col4" colwidth="31mm"/><tbody><row><entry namest="col1" nameend="col4" align="justify">* - LiquaPar Optima is phenoxyethanol (and) methylparaben (and) isopropylparaben (and) isobutylparaben (and) butylparaben and is available from ISP Labs of Wayne, NJ.</entry></row></tbody></tgroup></table></tables></p><p id="p0056" num="0056">All percentages in Table 3 are in percent by weight based upon 100% by weight of total shampoo.</p><heading id="h0014">Reference <u>Example 5</u></heading><p id="p0057" num="0057">Each anionic shampoo sample in Table 4 below was tested as follows. A standard mixed bacterial solution was prepared according to the following procedure. 2 agar slants of <i>Candida albicans</i> and 4 agar slants of <i>Aspergillus niger</i> were separately incubated at about 25 °C for about 48 hours and 7 days, respectively. Each slant was washed with 3 mL of sterile 0.85% saline solution, collected and macerated in a tissue grinder. Sufficient amounts of 0.85% saline solution were added to each slant to obtain a visual count under a microscope with a Neubauer Hemocytometer of each innoculum of <i>C. albicans</i> and <i>A. niger.</i> Equal volumes of each standardized innoculum of <i>C</i>. <i>albicans</i> and <i>A. niger</i> were mixed together to form the standardized mixed fungal solution.</p><p id="p0058" num="0058">40 g of each shampoo sample was inoculated with 0.4 mL of the standardized mixed fungal solution and mixed. 1 g of the mixture was added to a sterile 20 × 150 mm screw cap test tube.<!-- EPO <DP n="25"> --></p><p id="p0059" num="0059">9 mL of sterile D/E neutralizer broth was added to the test tube and mixed to form a 10<sup>-1</sup> dilution. Serial dilutions were prepared through to a 10<sup>-6</sup> dilution with phosphate buffered water. The serial dilutions were plated onto Sabourand dextrose agar and incubated 5 days at about 25 °C. Fungal counts were performed after 0 and 14 days. The results are shown in Table 9.</p><p id="p0060" num="0060">The anionic protein shampoo composition is described in Example 4. The shampoo samples were prepared by mixing the appropriate amounts of the preservatives and the anionic protein shampoo composition and heating the mixture to about 50 °C for about 15 minutes.
<tables id="tabl0007" num="0007"><table frame="all"><title><u>Table 4</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="78mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="18mm"/><colspec colnum="4" colname="col4" colwidth="18mm"/><thead><row><entry morerows="1" align="center" valign="top">Shampoo</entry><entry namest="col2" nameend="col4" align="center" valign="top">Fungal Plate Count (cfu/g)</entry></row><row><entry align="center" valign="top">Day 0</entry><entry align="center" valign="top">Day 7</entry><entry align="center" valign="top">Day 14</entry></row></thead><tbody><row><entry>Unpreserved Anionic Protein Shampoo Composition</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">4.5 × 10<sup>4</sup></entry><entry align="center">8.5 × 10<sup>4</sup></entry></row><row><entry>0.20 Cinnamaldehyde</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">&lt;10</entry><entry align="center">&lt;10</entry></row><row><entry>0.10% Cinnamaldehyde</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">3.0 × 10<sup>1</sup></entry><entry align="center">&lt;10</entry></row><row><entry>0.05% Cinnamaldehyde</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">8.0 × 10<sup>3</sup></entry><entry align="center">&lt;10</entry></row><row><entry>1.0% Benzyl Alcohol</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">6.0 × 10<sup>3</sup></entry><entry align="center">6.0 × 10<sup>4</sup></entry></row><row><entry>1.0% LiquaPar Optima</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">4.0 × 10<sup>4</sup></entry><entry align="center">3.0 × 10<sup>4</sup></entry></row></tbody></tgroup></table></tables></p><heading id="h0015">Reference <u>Example 6</u></heading><p id="p0061" num="0061">Each cream sample in Table 5 below was tested by the procedure described in Example 1. A glyceryl monostearate (GMS) cream as described in Table 3 below was prepared as follows. The polyoxyethylene glyceryl monostearate, glyceryl monostearate, cetearyl alcohol, and myristyl propionate were mixed and heated to 60 °C in a first container.<!-- EPO <DP n="26"> --> The glycerin and sterile deionized water were mixed and heated to 60 °C in a second container. The solution in the first container was poured into the second container. The second container was maintained at 60 °C for 10 minutes. The solution in the second container was allowed to cool. The pH of the solution was adjusted to pH 7 with sodium hydroxide to yield the GMS cream.
<tables id="tabl0008" num="0008"><table frame="all"><title><u>Table 5</u></title><tgroup cols="3"><colspec colnum="1" colname="col1" colwidth="45mm"/><colspec colnum="2" colname="col2" colwidth="68mm"/><colspec colnum="3" colname="col3" colwidth="28mm"/><thead><row><entry align="center" valign="top">Ingredient Trade Name</entry><entry align="center" valign="top">Chemical Name</entry><entry align="center" valign="top">Amount (% w/w)</entry></row></thead><tbody><row><entry>Aldosperse<sup>7</sup> MS-20 (Lonza)</entry><entry>Polyoxyethylene (POE) glyceryl monostearate</entry><entry align="center">4.00</entry></row><row><entry>Aldo<sup>7</sup> (Lonza)</entry><entry>Glyceryl monostearate</entry><entry align="center">6.00</entry></row><row><entry>TA 1618 (Proctor &amp; Gamble)</entry><entry>Cetearyl alcohol</entry><entry align="center">1.50</entry></row><row><entry>Lonzest<sup>7</sup> 143-S (Lonza)</entry><entry>Myristyl propionate</entry><entry align="center">8.00</entry></row><row><entry>Glycon<sup>7</sup> G-100 (Lonza)</entry><entry>Glycerin</entry><entry align="center">5.00</entry></row><row><entry>-</entry><entry>Sterile Deionized Water</entry><entry align="center">75.50</entry></row><row><entry namest="col1" nameend="col2" align="left">Total</entry><entry align="center">100.00</entry></row></tbody></tgroup></table></tables></p><p id="p0062" num="0062">The cream samples shown in Table 6 below were prepared by mixing the appropriate amounts of the preservatives and the GMS cream and heating the mixture to 50 °C for 10-15 minutes. The results are shown in Table 6 below.<!-- EPO <DP n="27"> -->
<tables id="tabl0009" num="0009"><table frame="all"><title><u>Table 6</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="41mm"/><colspec colnum="2" colname="col2" colwidth="22mm"/><colspec colnum="3" colname="col3" colwidth="22mm"/><colspec colnum="4" colname="col4" colwidth="22mm"/><thead><row><entry morerows="1" align="center" valign="top">Cream</entry><entry namest="col2" nameend="col4" align="center" valign="top"><i>S. aureus</i>, <i>P. aeruginosa</i>, and <i>E. coli</i> (cfu/g)</entry></row><row><entry align="center" valign="top">Day 0</entry><entry align="center" valign="top">Day 7</entry><entry align="center" valign="top">Day 14</entry></row></thead><tbody><row><entry>Unpreserved GMS Cream</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>0.25% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">&lt;10</entry><entry align="center">&lt;10</entry></row><row><entry>0.10% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">4.0 × 10<sup>4</sup></entry><entry align="center">9.3 × 10<sup>5</sup></entry></row></tbody></tgroup></table></tables></p><p id="p0063" num="0063">The cream samples shown in Table 7 below were prepared by mixing the appropriate amounts of the preservatives and the GMS cream and heating the mixture to 50 °C for 10-15 minutes. The results are shown in Table 7 below.
<tables id="tabl0010" num="0010"><table frame="all"><title><u>Table 7</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="41mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="18mm"/><colspec colnum="4" colname="col4" colwidth="18mm"/><thead><row><entry morerows="1" align="center" valign="top">Cream</entry><entry namest="col2" nameend="col4" align="center" valign="top">Fungal Plate Count (cfu/g)</entry></row><row><entry align="center" valign="top">Day 0</entry><entry align="center" valign="top">Day 7</entry><entry align="center" valign="top">Day 14</entry></row></thead><tbody><row><entry>Unpreserved GMS Cream</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">2.3 × 10<sup>5</sup></entry><entry align="center">1.5 × 10<sup>5</sup></entry></row><row><entry>0.25% Cinnamaldehyde</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">&lt;10</entry><entry align="center">&lt;10</entry></row><row><entry>0.10% Cinnamaldehyde</entry><entry align="center">1.0 × 10<sup>5</sup></entry><entry align="center">&lt;10</entry><entry align="center">&lt;10</entry></row></tbody></tgroup></table></tables></p><heading id="h0016">Reference <u>Example 7</u></heading><p id="p0064" num="0064">The procedure in Example 4 was repeated with the shampoo samples shown in Table 8 below. The results are shown in Table 8.<!-- EPO <DP n="28"> -->
<tables id="tabl0011" num="0011"><table frame="all"><title><u>Table 8</u></title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="78mm"/><colspec colnum="2" colname="col2" colwidth="22mm"/><colspec colnum="3" colname="col3" colwidth="22mm"/><colspec colnum="4" colname="col4" colwidth="22mm"/><thead><row><entry morerows="1" align="center" valign="top">Cream</entry><entry namest="col2" nameend="col4" align="center" valign="top"><i>S. aureus</i>, <i>P. aeruginosa</i>, and <i>E. coli</i> (cfu/g)</entry></row><row><entry align="center" valign="top">Day 0</entry><entry align="center" valign="top">Day 7</entry><entry align="center" valign="top">Day 14</entry></row></thead><tbody><row><entry>Unpreserved Anionic Protein shampoo Composition</entry><entry align="center">3.0 × 10<sup>6</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry><entry align="center">3.0 × 10<sup>7</sup></entry></row><row><entry>0.10% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>6</sup></entry><entry align="center">1.0 × 10<sup>1</sup></entry><entry align="center">&lt;10</entry></row><row><entry>0.05% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>6</sup></entry><entry align="center">6.5 × 10<sup>6</sup></entry><entry align="center">1.0 × 10<sup>7</sup></entry></row><row><entry>0.05% Glydant 2000™ *</entry><entry align="center">3.0 × 10<sup>6</sup></entry><entry align="center">2.0 × 10<sup>2</sup></entry><entry align="center">1.0 × 10<sup>2</sup></entry></row><row><entry>0.02% Glydant 2000™ and 0.025% Cinnamaldehyde</entry><entry align="center">3.0 × 10<sup>6</sup></entry><entry align="center">&lt;10</entry><entry align="center">&lt;10</entry></row></tbody></tgroup></table></tables></p><p id="p0065" num="0065">* - Glydant 2000<sup>™</sup> is a 70% solution of hydantoin species including about 36% dimethylol dimethyl hydantoin (DMDMH), about 29% monomethylol dimethylhydantoin (MMDMH), and about 5% dimethyl hydantoin (DMH); and 30% water and is available from Lonza, Inc. of Fair Lawn, NJ.</p><p id="p0066" num="0066">Synergism for the cinnamaldehyde/Glydant 2000<sup>™</sup> solutions in Table 8 against S. <i>aureus</i>, <i>P. aeruginosa</i>, and <i>E</i>. <i>coli</i> was calculated by the method described in <nplcit id="ncit0002" npl-type="s"><text>C.E. Kull et al., "Mixtures of Quaternary Ammonium Compounds and Long-chain Fatty Acids as Antifungal Agents", Applied Microbiology, 9:538-541 (1961</text></nplcit>). The synergism value (Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub>) in Table 7 was determined. Q<sub>A</sub> is the concentration of cinnamaldehyde (in percent by weight) in the mixture, which yielded 100% retardation of the bacteria, i.<i>e.</i>, resulted in a plate count of &lt;10 cfu/g after 14 days. Q<sub>a</sub> is the concentration of cinnamaldehyde alone (in percent by weight) required to yield 100% retardation of the bacteria. Q<sub>B</sub> is the concentration of Glydant 2000<sup>™</sup> (in percent by weight) in the mixture, which yielded 100% retardation of the<!-- EPO <DP n="29"> --> bacteria. Q<sub>b</sub> is the concentration of Glydant 2000<sup>™</sup> alone (in percent by weight) required to yield 100% retardation of the bacteria.</p><p id="p0067" num="0067">When the value of (Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub>) is less than one, the mixture is synergistic. Values for (Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub>) of 1 and greater than 1, represent an additive effect and an antagonistic effect, respectively.</p><p id="p0068" num="0068">The results are shown in Tables 9 and 10 below.
<tables id="tabl0012" num="0012"><table frame="all"><title><u>Table 9</u></title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="78mm"/><colspec colnum="2" colname="col2" colwidth="14mm"/><colspec colnum="3" colname="col3" colwidth="15mm"/><colspec colnum="4" colname="col4" colwidth="14mm"/><colspec colnum="5" colname="col5" colwidth="14mm"/><colspec colnum="6" colname="col6" colwidth="27mm"/><thead><row><entry namest="col1" nameend="col6" align="center" valign="top"><u>For Day 7</u></entry></row><row><entry align="center" valign="top">Preservative Mixture</entry><entry align="center" valign="top">Q<sub>A</sub></entry><entry align="center" valign="top">Q<sub>B</sub></entry><entry align="center" valign="top">Q<sub>a</sub></entry><entry align="center" valign="top">Q<sub>b</sub></entry><entry align="center" valign="top">Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub></entry></row></thead><tbody><row><entry>0.05% Glydant 2000™</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.05%</entry><entry align="center">-</entry><entry align="center">-</entry></row><row><entry>0.10% Cinnamaldehyde</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.1%</entry><entry align="center">-</entry></row><row><entry>0.02% Glydant 2000™ and 0.025% Cinnamaldehyde</entry><entry align="center">0.02%</entry><entry align="center">0.025%</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.65</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="30"> -->
<tables id="tabl0013" num="0013"><table frame="all"><title><u>Table 10</u></title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="78mm"/><colspec colnum="2" colname="col2" colwidth="14mm"/><colspec colnum="3" colname="col3" colwidth="15mm"/><colspec colnum="4" colname="col4" colwidth="14mm"/><colspec colnum="5" colname="col5" colwidth="14mm"/><colspec colnum="6" colname="col6" colwidth="27mm"/><thead><row><entry namest="col1" nameend="col6" align="center" valign="top"><u>For Day 14</u></entry></row><row><entry align="center" valign="top">Preservative Mixture</entry><entry align="center" valign="top">Q<sub>A</sub></entry><entry align="center" valign="top">Q<sub>B</sub></entry><entry align="center" valign="top">Q<sub>a</sub></entry><entry align="center" valign="top">Q<sub>b</sub></entry><entry align="center" valign="top">Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub></entry></row></thead><tbody><row><entry>0.05% Glydant 2000™</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.05%</entry><entry align="center">-</entry><entry align="center">-</entry></row><row><entry>0.10% Cinnamaldehyde</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.05%</entry><entry align="center">-</entry></row><row><entry>0.02% Glydant 2000™ and 0.025% Cinnamaldehyde</entry><entry align="center">0.02%</entry><entry align="center">0.025%</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.90</entry></row></tbody></tgroup></table></tables></p><heading id="h0017">Reference <u>Example 8</u></heading><p id="p0069" num="0069">The Minimum Inhibitory Concentration (MIC) of the preservative mixtures was tested. The MIC is the lowest concentration of an ingredient that will inhibit the growth of an organism. This study was conducted using the Hamilton Micro Lab AT Plus Autodilutor Liquid handling System. The programs for the auto-dilutor were based on Lonza's Standard Application Method SAPM# 412-01-1. The Hamilton Autodilutor was used to dilute the starting concentrations of the preservative combination by 50% using nutrient broth in 96 well micro titer plates and also to inoculate the microorganism in the test samples.</p><p id="p0070" num="0070">This preservatives tested were Isocil<sup>™</sup> (a blend of methyl isothiazolinone and methyl-chloro-isothiazolinone), Benzocil<sup>™</sup> (benzisothiazolinone) and Lonzagard<sup>™</sup> (benzethonium chloride), all of which are available from Lonza Inc. of Fair Lawn, NJ, in various concentrations and combinations with cinnamaldehyde. Controls were also included in each test plate. Each preservative combination was tested in duplicate against <i>Staphylococcus aureus</i> (ATCC # 6538) and <i>Escherichia coli</i> (ATCC #<!-- EPO <DP n="31"> --> 8739).</p><p id="p0071" num="0071">Test plates were diluted by the Hamilton Autodilutor and then inoculated with the test organism to achieve approximately 10<sup>6</sup> colony forming units / gram in the test sample (cfu/g). The plates were then incubated in a 32 degree Celsius oven for 72 hours. Results were determined by checking for growth in the test samples versus the control wells on each plate (visual determination of turbidity in the wells). The MIC shown below in Table 11 was reported as the lowest test levels of preservative or preservative blend that did not show any growth.</p><p id="p0072" num="0072">A mixture of 7.5 ppm (active) Benzocil<sup>™</sup> and 25 ppm cinnamaldehyde effectively inhibited growth. Also, a mixture of 0.47 ppm (active) Isocil<sup>™</sup> and 6.3 ppm cinnamaldehyde effectively inhibited growth.
<tables id="tabl0014" num="0014"><table frame="all"><title><u>Table 11</u></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="53mm"/><colspec colnum="2" colname="col2" colwidth="31mm"/><thead><row><entry align="center" valign="top">Test Material</entry><entry align="center" valign="top">MIC for <i>S. Aureus</i></entry></row></thead><tbody><row><entry align="center">Cinnamaldehyde</entry><entry align="center">125 ppm</entry></row><row><entry align="center">Isocil™ (Isothiazolinone)</entry><entry align="center">0.585 ppm (active)</entry></row><row><entry align="center">Benzocil™ (Benzoisothiazolinone)</entry><entry align="center">9.375 ppm (active)</entry></row></tbody></tgroup></table></tables></p><p id="p0073" num="0073">Synergism values for the Isocil<sup>™</sup>/cinnamaldehyde and Benzocil<sup>™</sup>/cinnamaldehyde combinations were calculated from the MIC values reported in Table 11 by the method described in Kull, <i>supra</i>, referred to above, and are set forth in Tables 12 and 13, below.<!-- EPO <DP n="32"> -->
<tables id="tabl0015" num="0015"><table frame="all"><title><u>Table 12</u></title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="81mm"/><colspec colnum="2" colname="col2" colwidth="14mm"/><colspec colnum="3" colname="col3" colwidth="14mm"/><colspec colnum="4" colname="col4" colwidth="14mm"/><colspec colnum="5" colname="col5" colwidth="14mm"/><colspec colnum="6" colname="col6" colwidth="27mm"/><thead><row><entry align="center" valign="top">Preservative Mixture</entry><entry align="center" valign="top">Q<sub>A</sub></entry><entry align="center" valign="top">Q<sub>B</sub></entry><entry align="center" valign="top">Q<sub>a</sub></entry><entry align="center" valign="top">Q<sub>b</sub></entry><entry align="center" valign="top">Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub></entry></row></thead><tbody><row><entry>0.585 ppm (active) Isocil™</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.585</entry><entry align="center">-</entry><entry align="center">-</entry></row><row><entry>125 ppm Cinnamaldehyde</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">125</entry><entry align="center">-</entry></row><row><entry>0.47 ppm (active) Isocil™ and 6.3 ppm Cinnamaldehyde</entry><entry align="center">0.47</entry><entry align="center">6.3</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">0.85</entry></row></tbody></tgroup></table></tables>
<tables id="tabl0016" num="0016"><table frame="all"><title><u>Table 13</u></title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="84mm"/><colspec colnum="2" colname="col2" colwidth="14mm"/><colspec colnum="3" colname="col3" colwidth="14mm"/><colspec colnum="4" colname="col4" colwidth="15mm"/><colspec colnum="5" colname="col5" colwidth="14mm"/><colspec colnum="6" colname="col6" colwidth="27mm"/><thead><row><entry align="center" valign="top">Preservative Mixture</entry><entry align="center" valign="top">Q<sub>A</sub></entry><entry align="center" valign="top">Q<sub>B</sub></entry><entry align="center" valign="top">Q<sub>a</sub></entry><entry align="center" valign="top">Q<sub>b</sub></entry><entry align="center" valign="top">Q<sub>A</sub>/Q<sub>a</sub> + Q<sub>B</sub>/Q<sub>b</sub></entry></row></thead><tbody><row><entry>9.375 ppm (active) Benzocil™</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">&gt;9.375</entry><entry align="center">-</entry><entry align="center">-</entry></row><row><entry>125 ppm Cinnamaldehyde</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">&gt;125</entry><entry align="center">-</entry></row><row><entry>7.5 ppm (active) Benzocil™ and 25 ppm Cinnamaldehyde</entry><entry align="center">7.5</entry><entry align="center">25</entry><entry align="center">-</entry><entry align="center">-</entry><entry align="center">&lt;1.0</entry></row></tbody></tgroup></table></tables></p></description><claims mxw-id="PCLM56978294" lang="DE" load-source="patent-office"><!-- EPO <DP n="35"> --><claim id="c-de-01-0001" num="0001"><claim-text>Körperpflegeprodukt, umfassend eine antimikrobielle Zusammensetzung welche eine antimikrobiell wirksame Menge einer Mischung enthält, die
<claim-text>(a) Benzoesäure oder eines ihrer Salze, und</claim-text>
<claim-text>(b) δ-Gluconolacton,<br/>
und gegebenenfalls eines oder mehrere von</claim-text>
<claim-text>(c) Lemongrasöl,</claim-text>
<claim-text>(d) Zimtaldehyd,</claim-text>
<claim-text>(e) Sorbinsäure oder einem ihrer Salze,</claim-text>
<claim-text>(f) Erythorbinsäure oder einem ihrer Salze,</claim-text>
<claim-text>(g) Arabinogalactan (Galactoarabinan),</claim-text>
<claim-text>(h) einer aus Hopfenextrakten erhältlichen Hexahydro-iso-alpha-säure oder Tetrahydro-iso-alpha-säure, oder einem Gemisch derselben, und</claim-text>
<claim-text>(i) Öl von <i>Achillea fragrantissima</i> (<i>Santolina fragrantissima</i> Forssk., Wohlriechende Schafgarbe)</claim-text>
umfasst.</claim-text></claim><claim id="c-de-01-0002" num="0002"><claim-text>Körperpflegeprodukt nach Anspruch 1, worin das Salz der Benzoesäure Natriumbenzoat ist.</claim-text></claim><claim id="c-de-01-0003" num="0003"><claim-text>Körperpflegeprodukt nach Anspruch 2, worin das Gewichtsverhältnis von δ-Gluconolacton und Natriumbenzoat 1:1 1 bis 5:1 und vorzugsweise 3:1 ist.</claim-text></claim><claim id="c-de-01-0004" num="0004"><claim-text>Körperpflegeprodukt nach Anspruch 1, worin die antimikrobielle Zusammensetzung zusätzlich ein Lösungsmittel enthält.</claim-text></claim><claim id="c-de-01-0005" num="0005"><claim-text>Körperpflegeprodukt nach Anspruch 4, worin das Lösungsmittel ausgewählt ist aus Wasser, Glykolen, Alkoholen und Mischungen derselben.</claim-text></claim><claim id="c-de-01-0006" num="0006"><claim-text>Körperpflegeprodukt nach Anspruch 5, worin das Lösungsmittel eine Mischung aus Wasser und einem Glykol ist.</claim-text></claim><claim id="c-de-01-0007" num="0007"><claim-text>Körperpflegeprodukt nach Anspruch 6, worin das Glykol Glycerin ist.<!-- EPO <DP n="36"> --></claim-text></claim><claim id="c-de-01-0008" num="0008"><claim-text>Körperpflegeprodukt nach Anspruch 5, worin das Lösungsmittel eine Mischung aus Wasser und einem Alkohol ist.</claim-text></claim><claim id="c-de-01-0009" num="0009"><claim-text>Körperpflegeprodukt nach Anspruch 8, worin der Alkohol Ethanol ist.</claim-text></claim><claim id="c-de-01-0010" num="0010"><claim-text>Körperpflegeprodukt nach Anspruch 1, worin die antimikrobielle Zusammensetzung in einer Konzentration von 0,1 bis 2 Gew.-%, bezogen auf 100% Gesamtgewicht des Produkts, vorhanden ist.</claim-text></claim><claim id="c-de-01-0011" num="0011"><claim-text>Verfahren zum Töten und/oder der Hemmung des Wachstums von Mikroorganismen auf einem Substrat, umfassend das Aufbringen einer wirksamen Menge der antimikrobiellen Zusammensetzung gemäss Anspruch 1 auf das Substrat, wobei das Substrat ein Körperpflegeprodukt ist.</claim-text></claim><claim id="c-de-01-0012" num="0012"><claim-text>Verfahren nach Anspruch 11, worin die Mikroorganismen aus <i>S</i>. <i>aureus, P. aeruginosa, E. coli, Candida albicans, Aspergillus niger</i> und <i>Phytophthora ramorum</i> ausgewählt sind.</claim-text></claim></claims><claims mxw-id="PCLM56978295" lang="EN" load-source="patent-office"><!-- EPO <DP n="33"> --><claim id="c-en-01-0001" num="0001"><claim-text>A personal care product comprising an antimicrobial composition comprising an antimicrobial effective amount of a mixture comprising:
<claim-text>(a) benzoic acid, or a salt thereof; and</claim-text>
<claim-text>(b) δ-gluconolactone.</claim-text>
and, optionally, one or more of:
<claim-text>(c) lemon grass oil;</claim-text>
<claim-text>(d) cinnamaldehyde;</claim-text>
<claim-text>(e) sorbic acid, or a salt thereof;</claim-text>
<claim-text>(f) erythorbic acid, or a salt thereof;</claim-text>
<claim-text>(g) arabinogalactan (galactoarabinan);</claim-text>
<claim-text>(h) a hexahydro-iso-alpha-acid or tetrahydro-iso-alpha-acid obtainable from hops extracts, or a mixture thereof;</claim-text>
<claim-text>(i) <i>Achillea fragrantissima</i> (<i>Santolina fragrantissima</i> Forssk., lavender cotton) oil.</claim-text></claim-text></claim><claim id="c-en-01-0002" num="0002"><claim-text>The personal care product of claim 1, wherein the salt of benzoic acid is sodium benzoate.</claim-text></claim><claim id="c-en-01-0003" num="0003"><claim-text>The personal care product of claim 2, wherein the weight ratio of δ-gluconolactone and sodium benzoate is 1:1 to 5:1, preferably 3:1.</claim-text></claim><claim id="c-en-01-0004" num="0004"><claim-text>The personal care product of claim 1, wherein the antimicrobial composition further comprises a solvent.</claim-text></claim><claim id="c-en-01-0005" num="0005"><claim-text>The personal care product of claim 4, wherein the solvent is selected from water, glycols, alcohols, and mixtures thereof.</claim-text></claim><claim id="c-en-01-0006" num="0006"><claim-text>The personal care product of claim 5, wherein the solvent is a mixture of water and a glycol.</claim-text></claim><claim id="c-en-01-0007" num="0007"><claim-text>The personal care product of claim 6, wherein the glycol is glycerin.<!-- EPO <DP n="34"> --></claim-text></claim><claim id="c-en-01-0008" num="0008"><claim-text>The personal care product of claim 5, wherein the solvent is a mixture of water and an alcohol.</claim-text></claim><claim id="c-en-01-0009" num="0009"><claim-text>The personal care product of claim 8, wherein the alcohol is ethanol.</claim-text></claim><claim id="c-en-01-0010" num="0010"><claim-text>The personal care product of claim 1, wherein the antimicrobial composition is present at a concentration of from 0.1 to 2% by weight, based on 100% weight of the total product.</claim-text></claim><claim id="c-en-01-0011" num="0011"><claim-text>A method of killing and/or inhibiting the growth of microorganisms on a substrate, comprising applying an effective amount of the antimicrobial composition of claim 1 to the substrate, said substrate being a personal care product.</claim-text></claim><claim id="c-en-01-0012" num="0012"><claim-text>The method of claim 11, wherein the microorganisms are selected from <i>S. aureus</i>, <i>P. aeruginosa</i>, <i>E. coli</i>, <i>Candida albicans, Aspergillus niger</i> and <i>Phytophthora ramorum</i>.</claim-text></claim></claims><claims mxw-id="PCLM56978296" lang="FR" load-source="patent-office"><!-- EPO <DP n="37"> --><claim id="c-fr-01-0001" num="0001"><claim-text>Produit de soin personnel comprenant une composition antimicrobienne comprenant une quantité efficace antimicrobienne d'un mélange comprenant :
<claim-text>(a) de l'acide benzoïque, ou un sel de celui-ci ; et</claim-text>
<claim-text>(b) de la δ-gluconolactone ;</claim-text>
et éventuellement, un ou plusieurs parmi :
<claim-text>(c) de l'huile essentielle de citronnelle ;</claim-text>
<claim-text>(d) du cinnamaldéhyde ;</claim-text>
<claim-text>(e) de l'acide sorbique, ou un sel de celui-ci ;</claim-text>
<claim-text>(f) de l'acide érythorbique, ou un sel de celui-ci ;</claim-text>
<claim-text>(g) un arabinogalactane (galactoarabinane) ;</claim-text>
<claim-text>(h) un hexahydro-iso-alpha-acide ou un tétrahydro-iso-alpha-acide pouvant être obtenu à partir d'extraits de houblon, ou un mélange de ceux-ci ;</claim-text>
<claim-text>(i) de l'huile d'<i>Achillea fragrantissima</i> (<i>Santolina fragrantissima</i> Forssk., santoline).</claim-text></claim-text></claim><claim id="c-fr-01-0002" num="0002"><claim-text>Produit de soin personnel selon la revendication 1, dans lequel le sel de l'acide benzoïque est le benzoate de sodium.</claim-text></claim><claim id="c-fr-01-0003" num="0003"><claim-text>Produit de soin personnel selon la revendication 2, dans lequel le rapport pondéral de la δ-gluconolactone au benzoate de sodium va de 1:1 à 5:1, préférablement est de 3:1.</claim-text></claim><claim id="c-fr-01-0004" num="0004"><claim-text>Produit de soin personnel selon la revendication 1, dans lequel la composition antimicrobienne comprend en outre un solvant.</claim-text></claim><claim id="c-fr-01-0005" num="0005"><claim-text>Produit de soin personnel selon la revendication 4, dans lequel le solvant est choisi parmi l'eau, les glycols, les alcools, et des mélanges de ceux-ci.</claim-text></claim><claim id="c-fr-01-0006" num="0006"><claim-text>Produit de soin personnel selon la revendication 5, dans lequel le solvant est un mélange d'eau et d'un glycol.</claim-text></claim><claim id="c-fr-01-0007" num="0007"><claim-text>Produit de soin personnel selon la revendication 6, dans lequel le glycol est le glycérol.</claim-text></claim><claim id="c-fr-01-0008" num="0008"><claim-text>Produit de soin personnel selon la revendication 5, dans lequel le solvant est un mélange d'eau et d'un alcool.<!-- EPO <DP n="38"> --></claim-text></claim><claim id="c-fr-01-0009" num="0009"><claim-text>Produit de soin personnel selon la revendication 8, dans lequel l'alcool est l'éthanol.</claim-text></claim><claim id="c-fr-01-0010" num="0010"><claim-text>Produit de soin personnel selon la revendication 1, dans lequel la composition antimicrobienne est présente selon une concentration allant de 0,1 à 2% en poids, sur la base de 100% en poids du produit total.</claim-text></claim><claim id="c-fr-01-0011" num="0011"><claim-text>Méthode pour tuer et/ou inhiber la croissance de microorganismes sur un substrat, comprenant l'application d'une quantité efficace de la composition antimicrobienne selon la revendication 1 audit substrat, ledit substrat étant un produit de soin personnel.</claim-text></claim><claim id="c-fr-01-0012" num="0012"><claim-text>Méthode selon la revendication 11, dans laquelle les microorganismes sont choisis parmi <i>S</i>. <i>aureus, P. aeruginosa, E. coli, Candida albicans, Aspergillus niger</i> et <i>Phytophthora ramorum.</i></claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
